日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

JNK pathway suppression mediates insensitivity to combination endocrine therapy and CDK4/6 inhibition in ER+ breast cancer.

JNK通路抑制介导ER+乳腺癌对联合内分泌治疗和CDK4/6抑制剂的不敏感性

Alexandrou Sarah, Lee Christine S, Fernandez Kristine J, Wiharja Celine E, Eshraghi Leila, Reeves John, Reed Daniel A, Portman Neil, Phan Zoe, Milioli Heloisa H, Nikolic Iva, Cadell Antonia L, Croucher David R, Simpson Kaylene J, Lim Elgene, Hickey Theresa E, Millar Ewan K A, Alves Carla L, Ditzel Henrik J, Caldon C Elizabeth

The potential of epigenetic therapy to target the 3D epigenome in endocrine-resistant breast cancer

表观遗传疗法靶向内分泌耐药性乳腺癌三维表观基因组的潜力

Achinger-Kawecka, Joanna; Stirzaker, Clare; Portman, Neil; Campbell, Elyssa; Chia, Kee-Ming; Du, Qian; Laven-Law, Geraldine; Nair, Shalima S; Yong, Aliza; Wilkinson, Ashleigh; Clifton, Samuel; Milioli, Heloisa H; Alexandrou, Sarah; Caldon, C Elizabeth; Song, Jenny; Khoury, Amanda; Meyer, Braydon; Chen, Wenhan; Pidsley, Ruth; Qu, Wenjia; Gee, Julia M W; Schmitt, Anthony; Wong, Emily S; Hickey, Theresa E; Lim, Elgene; Clark, Susan J

Differential kynurenine pathway metabolism in highly metastatic aggressive breast cancer subtypes: beyond IDO1-induced immunosuppression

高转移性侵袭性乳腺癌亚型中犬尿氨酸途径代谢的差异:超越IDO1诱导的免疫抑制

Heng, Benjamin; Bilgin, Ayse A; Lovejoy, David B; Tan, Vanessa X; Milioli, Heloisa H; Gluch, Laurence; Bustamante, Sonia; Sabaretnam, Tharani; Moscato, Pablo; Lim, Chai K; Guillemin, Gilles J

Basal-like breast cancer: molecular profiles, clinical features and survival outcomes

基底样乳腺癌:分子特征、临床特征和生存结局

Milioli, Heloisa H; Tishchenko, Inna; Riveros, Carlos; Berretta, Regina; Moscato, Pablo

Iteratively refining breast cancer intrinsic subtypes in the METABRIC dataset

在METABRIC数据集中迭代细化乳腺癌内在亚型

Milioli, Heloisa H; Vimieiro, Renato; Tishchenko, Inna; Riveros, Carlos; Berretta, Regina; Moscato, Pablo